Smruthi Organics Ltd Stock Price Today (NSE: SMRUTHIORG)
Fundamental Score
Smruthi Organics Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Smruthi Organics Ltd share price today is ₹121.70, up +0.00% on NSE/BSE as of 18 June 2026. Smruthi Organics Ltd (SMRUTHIORG) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹141.65 (Cr). The 52-week high for SMRUTHIORG share price is ₹164.00 and the 52-week low is ₹95.00. At a P/E ratio of 30.33x, SMRUTHIORG is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 5.04% and a debt-to-equity ratio of 0.13.
Smruthi Organics Ltd Share Price Chart — NSE/BSE Historical Performance
Smruthi Organics Ltd share price chart: -0.34% return over the past month. 52-week high ₹164.00, 52-week low ₹95.00.
Smruthi Organics Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹122.90 | ₹124.00 | ₹121.70 | ₹121.70 | 423.00 (Cr) | |
| ₹125.20 | ₹125.25 | ₹120.00 | ₹121.70 | 2.85K (Cr) | |
| ₹117.10 | ₹126.00 | ₹113.50 | ₹123.50 | 6.06K (Cr) | |
| ₹118.25 | ₹118.35 | ₹114.05 | ₹116.25 | 4.26K (Cr) | |
| ₹119.45 | ₹120.00 | ₹118.25 | ₹118.25 | 1.19K (Cr) | |
| ₹122.75 | ₹122.75 | ₹117.15 | ₹119.45 | 1.18K (Cr) | |
| ₹118.80 | ₹121.00 | ₹117.15 | ₹119.00 | 2.13K (Cr) | |
| ₹121.00 | ₹121.00 | ₹116.95 | ₹117.35 | 722.00 (Cr) | |
| ₹113.50 | ₹116.80 | ₹111.75 | ₹112.70 | 3.20K (Cr) | |
| ₹116.00 | ₹116.00 | ₹113.85 | ₹114.00 | 913.00 (Cr) |
Smruthi Organics Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹125.20 | ₹125.25 | ₹120.00 | ₹121.70 | -2.80% | |
| ₹117.80 | ₹126.00 | ₹109.40 | ₹123.50 | +4.84% | |
| ₹96.01 | ₹123.37 | ₹95.00 | ₹114.85 | +19.62% | |
| ₹110.95 | ₹130.50 | ₹96.00 | ₹96.50 | -13.02% | |
| ₹117.55 | ₹123.80 | ₹106.30 | ₹112.05 | -4.68% | |
| ₹119.75 | ₹123.35 | ₹109.90 | ₹119.85 | +0.08% | |
| ₹127.10 | ₹131.90 | ₹112.70 | ₹116.90 | -8.03% | |
| ₹130.00 | ₹140.00 | ₹123.10 | ₹128.45 | -1.19% | |
| ₹131.75 | ₹139.00 | ₹122.95 | ₹128.15 | -2.73% | |
| ₹118.00 | ₹164.00 | ₹109.75 | ₹128.00 | +8.47% | |
| ₹136.25 | ₹146.60 | ₹111.90 | ₹113.05 | -17.03% | |
| ₹121.80 | ₹138.00 | ₹117.00 | ₹136.25 | +11.86% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Smruthi Organics Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Smruthi Organics Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SMRUTHIORG across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Robust Profit Growth (164.10%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Conservative Debt Levels (D/E: 0.13)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (64.73%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (5.04%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.98%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Limited Growth History (-0.78% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-15.94% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-15.88% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Smruthi Organics Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Smruthi Organics Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Smruthi Organics LtdSmruthi Organic...Selected✓ SMRUTHIORG • 540686 | 35.2/100 | ₹121.70₹122 | ₹141.65₹141.65 | 30.33Average 30.3 Average | 5.04%Poor 5.04% Poor | 7.98%Poor 7.98% Poor | 0.13Excellent 0.1 Excellent | -15.88%Poor -15.88% Poor | -0.78%Poor -0.78% Poor | 1.21% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Smruthi Organics Ltd PE Ratio History
Historical price-to-earnings ratio for SMRUTHIORG — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹3.14 | ₹119.75 | 38.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Smruthi Organics Ltd Dividend History
Annual cash dividends paid by SMRUTHIORG — dividend yield 1.21%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹1.72 Cr |
| FY 2024 | ₹2.29 Cr |
| FY 2023 | ₹3.43 Cr |
| FY 2022 | ₹3.43 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Smruthi Organics Ltd Quarterly Performance
Latest quarterly metrics for SMRUTHIORG — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
7.52%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
164.10%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-0.78%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-15.88%
Compounded annual net profit growth over 5 years
Smruthi Organics Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SMRUTHIORG — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Smruthi Organics Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Smruthi Organics Ltd (SMRUTHIORG) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Smruthi Organics Ltd
About SMRUTHIORG (Smruthi Organics Ltd)
Smruthi Organics Ltd is a prominent Indian pharmaceutical manufacturer specializing in the production and distribution of Active Pharmaceutical Ingredients (APIs). The company focu...ses on developing and supplying a diverse portfolio of high-quality APIs, catering to the needs of pharmaceutical companies across the Indian market. With a strong emphasis on research and development, Smruthi Organics continually strives to expand its product offerings and improve existing manufacturing processes to ensure the delivery of safe and effective pharmaceutical ingredients. The company's commitment to quality and innovation has solidified its position as a reliable and trusted partner within the Indian pharmaceutical industry. Smruthi Organics offers a robust range of APIs designed to address prevalent health concerns. Their cardiovascular API offerings include vital ingredients like amlodipine besylate, losartan potassium, and valsartan, along with advanced iterations such as s-amlodipine besilate and s-amlodipine malelate. In the realm of anti-diabetic medications, Smruthi Organics provides crucial APIs like metformin HCL, vildagliptin, teneligliptin, and dapagliflozin, supporting the production of treatments for diabetes management. Additionally, their portfolio extends to anti-infective APIs, featuring essential ingredients such as ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, enabling the formulation of drugs targeting various infectious diseases. Dedicated to upholding the highest standards of quality and regulatory compliance, Smruthi Organics operates state-of-the-art manufacturing facilities equipped with advanced technology and adheres to stringent quality control measures. Their commitment to excellence is reflected in their adherence to Good Manufacturing Practices (GMP) and other relevant industry standards. Smruthi Organics' dedication to sustainability and ethical business practices further enhances its reputation as a responsible and trustworthy API supplier, contributing to the well-being of patients and the advancement of the pharmaceutical industry in India.
Company Details
Key Leadership
Corporate Events
SMRUTHIORG Share Price: Frequently Asked Questions
What is the current share price of Smruthi Organics Ltd?
Smruthi Organics Ltd (SMRUTHIORG) trades at ₹121.70 on NSE and BSE. Market cap ₹141.65 (Cr). Educational data only.
What is the P/E ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd has a P/E of 30.33x vs industry average 31.77x.
What is the Bull Run score for Smruthi Organics Ltd?
Smruthi Organics Ltd has a Bull Run score of 35.2/100 based on 25+ financial parameters.
Does Smruthi Organics Ltd pay dividends?
Smruthi Organics Ltd has a dividend yield of 1.21%. Past dividends don't guarantee future payments.
What is the ROE of Smruthi Organics Ltd?
Smruthi Organics Ltd has ROE of 5.04%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Smruthi Organics Ltd?
Smruthi Organics Ltd has debt-to-equity of 0.13.
Is Smruthi Organics Ltd a good investment?
Bull Run gives Smruthi Organics Ltd a score of 35.2/100. This is not investment advice — consult a SEBI-registered advisor.